NVS vs. XOM
NVS (Novartis AG) and XOM (Exxon Mobil Corporation) are both stocks. NVS operates in Drug Manufacturers - General (Healthcare), while XOM operates in Oil & Gas Integrated (Energy). Over the past 10 years, NVS returned 10.33%/yr vs 10.04%/yr for XOM. At a 0.27 correlation, their price movements are largely independent.
Performance
NVS vs. XOM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVS achieves a 9.43% return, which is significantly lower than XOM's 27.80% return. Both investments have delivered pretty close results over the past 10 years, with NVS having a 10.33% annualized return and XOM not far behind at 10.04%.
NVS
- 1D
- -1.84%
- 1M
- 0.27%
- YTD
- 9.43%
- 6M
- 15.91%
- 1Y
- 27.84%
- 3Y*
- 17.18%
- 5Y*
- 13.87%
- 10Y*
- 10.33%
XOM
- 1D
- 1.22%
- 1M
- 5.68%
- YTD
- 27.80%
- 6M
- 32.61%
- 1Y
- 50.17%
- 3Y*
- 16.03%
- 5Y*
- 23.83%
- 10Y*
- 10.04%
NVS vs. XOM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVS Novartis AG | 9.43% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 5.95% | 19.42% |
XOM Exxon Mobil Corporation | 27.80% | 15.98% | 11.26% | -6.26% | 87.41% | 57.58% | -36.21% | 7.23% | -15.09% | -3.81% |
Correlation
The correlation between NVS and XOM is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 1996 | 0.27 |
The correlation between NVS and XOM shifts across timeframes, from -0.09 (1 year) to 0.27 (all time), reflecting how their relationship changes across market environments.
Fundamentals
NVS:
$280.54B
XOM:
$634.77B
NVS:
$6.99
XOM:
$5.93
NVS:
20.95
XOM:
25.60
NVS:
1.42
XOM:
1.19
NVS:
5.06
XOM:
1.99
NVS:
7.28
XOM:
2.50
NVS:
$56.05B
XOM:
$326.01B
NVS:
$42.19B
XOM:
$83.11B
NVS:
$22.40B
XOM:
$60.44B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVS vs. XOM — Risk / Return Rank
NVS
XOM
NVS vs. XOM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and Exxon Mobil Corporation (XOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NVS | XOM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.71 | ||
| Sortino ratioReturn per unit of downside risk | -0.69 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.34 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 2.21 | 3.21 | -1.00 |
| Martin ratioReturn relative to average drawdown | 5.43 | 8.97 | -3.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NVS | XOM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.36 | 2.07 | -0.71 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.74 | 0.90 | -0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.53 | 0.36 | +0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.48 | -0.06 |
Drawdowns
NVS vs. XOM - Drawdown Comparison
The maximum NVS drawdown since its inception was -42.10%, smaller than the maximum XOM drawdown of -62.40%. Use the drawdown chart below to compare losses from any high point for NVS and XOM.
Loading charts...
Drawdown Indicators
| NVS | XOM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.10% | -62.40% | +20.30% |
Max Drawdown (1Y)Largest decline over 1 year | -12.65% | -15.69% | +3.04% |
Max Drawdown (3Y)Largest decline over 3 years | -19.95% | -18.92% | -1.03% |
Max Drawdown (5Y)Largest decline over 5 years | -20.42% | -20.51% | +0.09% |
Max Drawdown (10Y)Largest decline over 10 years | -26.03% | -61.34% | +35.31% |
Current DrawdownCurrent decline from peak | -10.52% | -10.90% | +0.38% |
Average DrawdownAverage peak-to-trough decline | -10.93% | -10.20% | -0.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 5.61% | -0.47% |
Volatility
NVS vs. XOM - Volatility Comparison
The current volatility for Novartis AG (NVS) is 6.16%, while Exxon Mobil Corporation (XOM) has a volatility of 9.20%. This indicates that NVS experiences smaller price fluctuations and is considered to be less risky than XOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVS | XOM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.16% | 9.20% | -3.04% |
Volatility (6M)Calculated over the trailing 6-month period | 14.45% | 20.29% | -5.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.63% | 24.44% | -3.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.85% | 26.73% | -7.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.62% | 28.19% | -8.57% |
Dividends
NVS vs. XOM - Dividend Comparison
NVS's dividend yield for the trailing twelve months is around 3.26%, more than XOM's 2.69% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVS Novartis AG | 3.26% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
XOM Exxon Mobil Corporation | 2.69% | 3.32% | 3.57% | 3.68% | 3.22% | 5.70% | 8.44% | 4.92% | 4.74% | 3.66% | 3.30% | 3.69% |
Financials
NVS vs. XOM - Financials Comparison
This section allows you to compare key financial metrics between Novartis AG and Exxon Mobil Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVS vs. XOM - Profitability Comparison
NVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.
XOM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported a gross profit of 31.36B and revenue of 83.16B. Therefore, the gross margin over that period was 37.7%.
NVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.
XOM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported an operating income of 5.29B and revenue of 83.16B, resulting in an operating margin of 6.4%.
NVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.
XOM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported a net income of 4.18B and revenue of 83.16B, resulting in a net margin of 5.0%.
Frequently Asked Questions
NVS and XOM have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XOM has higher volatility (9.20%) compared to NVS (6.16%). In terms of maximum drawdown, NVS dropped -42.10% vs XOM's -62.40%.
XOM currently has the higher Sharpe Ratio (2.07 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVS and XOM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer